We were pleased to be invited to present at the recent 2024 AI & Robotics Venture Fair in Pittsburgh, hosted by Innovation Works and Carnegie Mellon University. Douglas Descalzi shared the growing challenges the US health system has in medication management; the critical role of sensing and digital visibility to address unmet needs, automate, and apply AI; and Thiopoly's progress toward solutions for the future of healthcare. Thanks to Jordan Marinkovich, MBA for the opportunity and organizing the event. Photo credits: https://lnkd.in/eGWygeUm
关于我们
We create digital visibility for pharmacy, to make medication management more agile, intuitive, equitable and efficient. We use sensing, IoT, AI, Cloud, and mobile technologies to create scalable, frictionless, grab-and-go solutions for the future of healthcare. Digital visibility is the foundation for AI and the autonomous pharmacy
- 网站
-
www.thiopoly.com
Thiopoly的外部链接
- 所属行业
- 科技、信息和网络
- 规模
- 1 人
- 总部
- Pittsburgh，Pennsylvania
- 类型
- 私人持股
地点
-
主要
获取路线
US，Pennsylvania，Pittsburgh
Thiopoly员工
动态
-
We are excited to share that our DVRx pilot is underway. We are now live at 4 locations with our first pilot customer, supporting their cardiac ICU, IV compounding cleanroom, and consolidated service center. DVRx is intended assess the impact of new sensing, Internet-of-Things (IoT), Mobile, and Cloud/AI technology on the persistent lack of digital visibility in medication management. Additional pilot customers in our first cohort will go live shortly. We look forward to sharing insights and results from DVRx, and how we can help reduce costs and improve patient care for health systems and their patients around the world.?
-
-
We are pleased to announce closure of Pre-Seed funding for Thiopoly, and the launch of our Digital Visibility in Pharmacy (DVRx) pilot program.?Our Pre-Seed round kicked off with commitments from LifeX and Innovation Works, and was quickly over-subscribed.?The funding will enable us to continue our technical and commercial momentum. The DVRx program is our next step toward commercialization of Thio , which seeks to address the persistent lack of digital visibility of medications in healthcare.?In DVRx, we are partnering with leading US health systems to assess the impact of new sensing, Internet-of-Things (IoT), mobile, and Cloud/AI technologies on medication management.??We have already fully enrolled our first cohort in DVRx. For further news and progress on DVRx and the company, please follow Thiopoly on Linkedin.????
-
-
Thiopoly is pleased to announce the kickoff of the company’s pre-seed funding with commitments from LifeX and Innovation Works, two leading early stage investors in the Pittsburgh region.?Pre-seed funding will support Thiopoly through its planned pilot phase and further develop its core technology for commercial launch.?Funding is contingent on final due diligence and closing requirements.? ? We are excited to work with LifeX and IW as we pursue solutions to the lack of digital visibility in pharmacy and healthcare.?Their support, guidance, and network will be additional assets as we grow the company.
-
-
We are proud and grateful to be part of the Robotics Factory Scale Residency Program. Thank you to Kevin Dowling, Matthew Verlinich, Connor Claussen, and Andrew Katon for your support. https://lnkd.in/eQVxG_cx
We are proud to announce the companies accepted into the?Scale Residency program! ESTAT Actuation,?KEF Robotics,?Thiopoly,?Thorne Baby, and?Piximo. Scale Residents receive one year of access to the Robotics Factory’s facilities, hands-on support, access to?cutting-edge tools, grant funding, connections to local manufacturers, and educational resources to support rapid prototyping and manufacturing. Kevin Dowling Matthew Verlinich Andrew Katon Connor Claussen Read more here: https://lnkd.in/eAH_QWRg
-
We need to think big and think different. Thank you Douglas Descalzi, James Stevenson, and Mohamed Magoury
Technologist & Executive | IoT | Mobile | Cloud & AI | Robotics & Automation | Healthcare & Lifescience
As we think about the future of healthcare and its inevitable convergence with AI, sensing and data only become more critical. In medication use and health system pharmacy, the cornerstone of data and foundation for intelligence is the digital visibility of drugs. Healthcare delivery is increasingly complex and constantly changing, which has created a significant digital visibility 'gap' to close. But achieving full digital visibility is worth the effort - it would unlock a tidal wave of opportunity and innovation that would improve care, reduce costs, and impact us all.
-
We are appreciative of the support and equally thrilled to work with Innovation Works to develop and build innovative technologies in the region.
We are thrilled to announce that Thiopoly has recently been awarded a Scalable grant. The grant, part of our Scalable Innovation Program, is intended to support entrepreneurs in scaling high-potential businesses in partnership with manufacturers in southwestern Pennsylvania. This funding will further enable Thiopoly to develop, pilot, and build its novel Internet of Things (IoT) solutions in healthcare.?Thiopoly is working to improve the digital visibility of drugs, to make care more agile, intuitive, equitable, and efficient.?The company’s first product is based on IoT, Cloud, AI, and mobile technologies that create frictionless, grab-and-go workflows in pharmacy.?
-